Meibomian gland morphology and tear osmolarity: Changes with accutane therapy

W. D. Mathers; W. J. Shields; M. S. Sachdev; W. M. Petroll; J. V. Jester

doi:10.1097/00003226-199107000-00002

Meibomian gland morphology and tear osmolarity: Changes with accutane therapy

W. D. Mathers, W. J. Shields, M. S. Sachdev, W. M. Petroll, J. V. Jester

Research output: Contribution to journal › Article › peer-review

125 Scopus citations

Abstract

We evaluated the meibomian gland function of 11 patients before and during treatment with isotretinoin (Accutane) by assessing tear osmolarity, meibomian gland morphology, tear production, rose bengal staining, and meibomian gland excreta. We found, during Accutane use, that atrophic by meibography. Excreta thickness increased from 1.7 ± 0.9 to 3.1 ± 1.2 (p < 0.005), and expressible excreta volume decreased from 1.52 ± 0.68 to 1.10 ± 0.3 (p < 0.05) (scale 1-4). We also found a significant increase in tear osmolarity from 304.9 ± 11 to 316.3 ± 10 mosmol/L (p < 0.005). There was no significant change in the Schirmer test during treatment. We suggest that the clinical symptoms of blepharitis during Accutane therapy are related to decreased meibomian gland function and consequent increased tear evaporation and tear osmolarity.

Original language	English (US)
Pages (from-to)	286-290
Number of pages	5
Journal	Cornea
Volume	10
Issue number	4
DOIs	https://doi.org/10.1097/00003226-199107000-00002
State	Published - Jan 1 1991

ASJC Scopus subject areas

Ophthalmology

Access to Document

10.1097/00003226-199107000-00002

Cite this

@article{72000c3ee2df4bc6bd4b47daf00f0f8a,

title = "Meibomian gland morphology and tear osmolarity: Changes with accutane therapy",

abstract = "We evaluated the meibomian gland function of 11 patients before and during treatment with isotretinoin (Accutane) by assessing tear osmolarity, meibomian gland morphology, tear production, rose bengal staining, and meibomian gland excreta. We found, during Accutane use, that atrophic by meibography. Excreta thickness increased from 1.7 ± 0.9 to 3.1 ± 1.2 (p < 0.005), and expressible excreta volume decreased from 1.52 ± 0.68 to 1.10 ± 0.3 (p < 0.05) (scale 1-4). We also found a significant increase in tear osmolarity from 304.9 ± 11 to 316.3 ± 10 mosmol/L (p < 0.005). There was no significant change in the Schirmer test during treatment. We suggest that the clinical symptoms of blepharitis during Accutane therapy are related to decreased meibomian gland function and consequent increased tear evaporation and tear osmolarity.",

author = "Mathers, {W. D.} and Shields, {W. J.} and Sachdev, {M. S.} and Petroll, {W. M.} and Jester, {J. V.}",

year = "1991",

month = jan,

day = "1",

doi = "10.1097/00003226-199107000-00002",

language = "English (US)",

volume = "10",

pages = "286--290",

journal = "Cornea",

issn = "0277-3740",

publisher = "Lippincott Williams and Wilkins",

number = "4",

}

TY - JOUR

T1 - Meibomian gland morphology and tear osmolarity

T2 - Changes with accutane therapy

AU - Mathers, W. D.

AU - Shields, W. J.

AU - Sachdev, M. S.

AU - Petroll, W. M.

AU - Jester, J. V.

PY - 1991/1/1

Y1 - 1991/1/1

N2 - We evaluated the meibomian gland function of 11 patients before and during treatment with isotretinoin (Accutane) by assessing tear osmolarity, meibomian gland morphology, tear production, rose bengal staining, and meibomian gland excreta. We found, during Accutane use, that atrophic by meibography. Excreta thickness increased from 1.7 ± 0.9 to 3.1 ± 1.2 (p < 0.005), and expressible excreta volume decreased from 1.52 ± 0.68 to 1.10 ± 0.3 (p < 0.05) (scale 1-4). We also found a significant increase in tear osmolarity from 304.9 ± 11 to 316.3 ± 10 mosmol/L (p < 0.005). There was no significant change in the Schirmer test during treatment. We suggest that the clinical symptoms of blepharitis during Accutane therapy are related to decreased meibomian gland function and consequent increased tear evaporation and tear osmolarity.

AB - We evaluated the meibomian gland function of 11 patients before and during treatment with isotretinoin (Accutane) by assessing tear osmolarity, meibomian gland morphology, tear production, rose bengal staining, and meibomian gland excreta. We found, during Accutane use, that atrophic by meibography. Excreta thickness increased from 1.7 ± 0.9 to 3.1 ± 1.2 (p < 0.005), and expressible excreta volume decreased from 1.52 ± 0.68 to 1.10 ± 0.3 (p < 0.05) (scale 1-4). We also found a significant increase in tear osmolarity from 304.9 ± 11 to 316.3 ± 10 mosmol/L (p < 0.005). There was no significant change in the Schirmer test during treatment. We suggest that the clinical symptoms of blepharitis during Accutane therapy are related to decreased meibomian gland function and consequent increased tear evaporation and tear osmolarity.

UR - http://www.scopus.com/inward/record.url?scp=0026327205&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026327205&partnerID=8YFLogxK

U2 - 10.1097/00003226-199107000-00002

DO - 10.1097/00003226-199107000-00002

M3 - Article

C2 - 1832371

AN - SCOPUS:0026327205

SN - 0277-3740

VL - 10

SP - 286

EP - 290

JO - Cornea

JF - Cornea

IS - 4

ER -

Meibomian gland morphology and tear osmolarity: Changes with accutane therapy

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this